6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings have informed clinical practice guidelines and policy, which now recommend that SMBG not be used routinely in this group (21–26).”
In the citing paper
“While the drug manufacturer is currently offering a savings card program for some patients for whom pricing is a barrier, payor coverage for tirzepatide will likely be a barrier to patient use, especially before tirzepatide has been officially recognized as a standard of care in professional guidelines. 2”
From Tirzepatide: Clinical review of the twincretin injectable (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“33% with metformin as initial pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (33).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Research works printed but not linked: 1
- Dicembrini, Impact of technology on glycemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion, Diabetes Obes Metab
Cited by
Items 601–700 of 846
Lord, J., & Odoi, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298182 · Cited by 3
Dumitrescu, A., Vitcu, G. M., Stoica, S., Susa, S. R., & Stoicescu, E. R. (2024) · Biomedicines · doi:10.3390/biomedicines12091989 · Cited by 4
“The cut-off for fasting glucose level was defined according to the American Diabetes Association [20].”
MethodDiabetes from Exocrine Pancreatic Disease
Fujimori, N., Ito, T., & Ogawa, Y. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch56 · Cited by 2
Glucagon and Its Underutilization in Diabetes Self-Management: A Teachable Moment
Wolfe, K., & Clements, J. N. (2022) · Clinical Diabetes · doi:10.2337/cd22-0015 · Cited by 1
Ito, K., Satoh, S., Kondo, Y., Tamura, H., Hasebe, M., & Terauchi, Y. (2022) · Diabetology International · doi:10.1007/s13340-022-00592-z · Cited by 1
Prattichizzo, F., & Ceriello, A. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00969-3 · Cited by 1
Glycemic outcomes of people with diabetes mellitus in Brazilian primary health care
Calixto, A. A. S., Franco, L. J., Banca, R. O. L., Medina, L. A. C., Torquato, M. T. D. C. G., Damasceno, M. M. C., Zanetti, M. L., & Teixeira, C. R. D. S. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01203-6 · Cited by 6
The comparison of sleep disorders between type-1 diabetic and non-diabetic children and adolescents
Saffari, F., Homaei, A., Dodangeh, S., Batebi, O., & Razzaghi, A. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01344-2 · Cited by 1
“Therefore, there were three divided groups including HbA1C 7% as good control, 7–8% as inadequate control, and greater than 8% as poor control [26].”
Insulinoma Unmasked Post Sleeve Gastrectomy With Incidental Renal Cell Carcinoma: A Rare Case
Goel, Y., Kurlekar, U., Chitharanjan, D. A., & Beke, A. (2024) · Cureus · doi:10.7759/cureus.60395 · Cited by 1
Spitzer, A. I., Rodbard, H. W., Iqbal, S. U., Nakazawa, M., DiGiorgi, M., & Winston, R. (2024) · The Journal of Arthroplasty · doi:10.1016/j.arth.2024.05.055 · Cited by 3
Establishment and application of autoverification system for HbA1c testing
Gao, R., Zhao, F., Xia, L., Ma, C., Hu, Y., Qi, Z., Cheng, X., & Qiu, L. (2024) · Biochemia Medica · doi:10.11613/bm.2024.030705 · Cited by 1
Achievement of ABC Goals in Type 2 Diabetes in Real-life
Chandalia, H. B., Jain, J. D., & Chandalia, S. H. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0730 · Cited by 1
Resta, C. D., Sacco, C., Trbos, M., Locatelli, M., Banfi, G., & Tomaiuolo, R. (2024) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462324000497 · Cited by 1
Shiyanbola, O. O., Maurer, M. A., Piper, M. E., Bolt, D. M., Sharp, L. K., Ouayogodé, M. H., & Fisher, E. B. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107804 · Cited by 1
“Have an A1C that is ≥8 % (indicates uncontrolled diabetes) [41] based on a point of care test.”
Harvengt, A., Maure, A., Beckers, M., Boutsen, L., Brunelle, C., Costenoble, E., & Lysy, P. A. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-05992-2 · Cited by 1
“Severe hypoglycemia (SH) is characterized by an event leading to significant impairment of consciousness, including convulsions and coma, and requiring external assistance by another person to administer the appropriate treatment [4].”
Ban, Y., Waki, K., Nakada, R., Isogawa, A., Miyoshi, K., Waki, H., Kato, S., Sawaki, H., Murata, T., Hirota, Y., et al. (2025) · JMIR Research Protocols · doi:10.2196/64023 · Cited by 1
Exogenous vs Endogenous Insulin Delivery: 2025
Patel, A., Todd, R., Owen‐Simon, N. L., & McCune, K. R. (2025) · Current Transplantation Reports · doi:10.1007/s40472-025-00468-6 · Cited by 1
“Optimizing for both glycemic control and quality of life, however, is important for encouraging patient engagement and long-term sustainability, thus HgbA1 C targets may be adjusted based on factors including age, life expectancy, comorbidities, and daily activities [23].”
InfluentialMohammed, A. G., Alibrahim, N. T. Y., & Al-Waeli, D. K. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6659722 · Cited by 3
“Poor glycemic control is associated with an 5 Journal of Diabetes Research increased risk of diabetes-related complications, including microvascular and macrovascular complications [13].”
Improving School Nurse Confidence With Continuous Glucose Monitoring Technology
Seiler, S., & McClanahan, R. (2025) · NASN School Nurse · doi:10.1177/1942602x251341902 · Cited by 1
Ashraf, T., Kumar, A., Tara, A., Memon, N., Muhammad, A., Turesh, M., Dev, S., Muhammad, N., Kumar, V., Hussain, T., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003392 · Cited by 2
“Therefore, we included titration B, which involved a weekly adjustment of 28 units and targeted a fasting glucose range of 80–130 mg/dL, aligning with American Diabetes Association guidelines [ 27 ] .”
Ji, L., Huang, D., Lin, X., Dong, X., Lü, L., Sun, Q., Sun, X., Mao, L., Zhao, S., Wang, Q., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70036 · Cited by 2
Associations between perceived stress and glycemic measures: gender and age as moderators
Tsai, M., Goh, C. E., Lee, M. H., Seah, F., Lim, M., Febriana, E., Fu, J., Yip, J. K., Preshaw, P. M., & Toh, S.-A. E. S. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005368 · Cited by 1
Estimated glucose disposal rate and risk of incident hyperuricemia: insights from CHARLS
Liao, Y., Zuo, M., Xu, T., Zhu, Y., Tang, J., Fan, L., & Zhang, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-22952-w · Cited by 1
García, D. G., Thabit, H., Nutter, P. W., & Harper, S. (2025) · JMIR Diabetes · doi:10.2196/72769 · Cited by 1
“Current guidelines recommend a time in range (TIR) of at least 16.8 hours per day (70%), corresponding to BG levels between 70 and 180 mg/dL (3.9 ‐ 10 mmol/L) for that proportion of time [15,16].”
InfluentialMohebbi, A., Kjøller, N.-K., Johansen, A. R., Bengtsson, H. L., Jensen, M. L., Stallknecht, B. M., & Mørup, M. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc58623.2025.11253142 · Cited by 1
Russo, E., Cappadona, F., Macciò, L., Vincenzo, J. D., Piaggio, M., Verzola, D., Chirco, G., Garibotto, G., Esposito, P. B., & Viazzi, F. C. (2025) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-025-00764-3 · Cited by 2
“Dosages have been modulated to minimize collateral effects and to optimize glucose control in accordance with ADA guidelines [ 21 ].”
Kumar, G., Seboletswe, P., Manhas, N., Ghumran, S., Gcabashe, N., Bhargava, G., Idris, A., Islam, M. S., & Singh, P. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70224 · Cited by 1
“Diabetes mellitus (DM), a chronic metabolic disease that causes increased blood glucose levels or hyperglycemia, is primarily characterized by inadequate insulin secretion and impaired organ response to insulin (Deswal et al. 2023; Konidala et al. 2020).”
Zhang, H., Wang, R. K., Wang, X., Luo, D., Li, R., Zhang, Q., Wu, Y., & Li, M. (2026) · Nursing Research · doi:10.1097/nnr.0000000000000885 · Cited by 1
Shilov, V. V., Litvyak, V. V., Zhurnia, A. A., Roslyakov, Y. F., & Витальевна, О. Т. (2026) · New Technologies · doi:10.47370/2072-0920-2025-21-4-121-144 · Cited by 1
Bashier, A. M., Rukhaimi, M. A., Alhadari, A. K., Hussein, D., Hassanein, M. M., Abdelgadir, E., Rashid, F., Alhelfi, M., Kumar, D. N., Alalawi, F. J. A., et al. (2026) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0045-1814429 · Cited by 1
“31,32 An active urinary sediment (containing red or white blood cells or cellular casts) suggests an alternative or additional cause of kidney disease.”
Digital Twin Applications in Diabetes Management: Scoping Review
Rad, F. S., Jafarpour, M., Bitaraf, E., Khaleghdadi, K., & Li, J. (2026) · JMIR Diabetes · doi:10.2196/83059 · Cited by 3
Eruptive xanthomas secondary to severe hypertriglyceridemia
Hopper, W., Veria, S., Glosser, L. D., Garg, A., Awad, M. T., Smith, J. D., & Din, S. U. (2021) · Global Journal of Medical and Clinical Case Reports · doi:10.17352/2455-5282.000142 · Cited by 1
Principles of Diabetes Care and Lifestyle Modification
Moon, M. K. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_8 · Cited by 3
Anonna, S. N., Hussain, M. S., Hossain, S. S., & Hossain, M. S. (2021) · Diabetes Research - Open Journal · doi:10.17140/droj-7-149 · Cited by 1
Chou, A., Carloni, R., Xue, W., Seeram, V. K., & Ferreira, J. (2022) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002229 · Cited by 1
Psychometric Properties of Turkish Version of Hypoglycemia Attitudes and Behavior Scale
İnkaya, B. V., & Düzalan, Ö. B. (2022) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.992579 · Cited by 1
Bayona, M. M. (2022) · Interciencia médica · doi:10.56838/icmed.v12i1.78 · Cited by 1
Lawal, Y. (2022) · Journal of the International Foot & Ankle Foundation · doi:10.55067/jifaf.v1i8.24 · Cited by 1
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and sarcopenia
Almeida, J. M. G., López, M. L., Burgos, R., Matía-Martín, P., Milla, S. P., París, A. S., Murillo, A. Z., Martínez, J. J. A., Fullana, A. A., Chinchetru, M. A. J., et al. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.04507 · Cited by 4
İncekara, M., & Suvak, Ö. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0059 · Cited by 1
Hayek, A. A., Alzahrani, W. M., Sobki, S. H., Alsaeed, A. H., & Dawish, M. A. A. (2023) · Cureus · doi:10.7759/cureus.33416 · Cited by 4
A Survey Snapshot Measuring Insulin Underuse in a Primary Care Clinic
Willcoxon, T., & Hess, R. (2023) · The Annals of Family Medicine · doi:10.1370/afm.2899 · Cited by 1
Preoperatively elevated HbA1c levels can meaningfully improve following total joint arthroplasty
Shichman, I., Oakley, C. T., Konopka, J. A., Rozell, J. C., Schwarzkopf, R. M., & Lajam, C. M. (2023) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-023-04765-6 · Cited by 1
Chou, L., Raji, M. A., Yu, X., & Kuo, Y. (2023) · International Journal of Behavioral Medicine · doi:10.1007/s12529-023-10172-3 · Cited by 3
“Optimal glycemic management—as measured by glycosylated hemoglobin level (HbA1C)—remains the recommended strategy to prevent and reduce long-term diabetes complications [2].”
A Multidisciplinary Quality Improvement Program to Improve Diabetes Care at a Free Clinic
Hopper, W. A., Ruane, P. W., DiMucci-Ward, J., & Ables, A. Z. (2023) · Cureus · doi:10.7759/cureus.36745 · Cited by 3
Manov, A. E., Dhillon, G. S., Chauhan, S., Asllanaj, B., & Uy, E. S. (2023) · Cureus · doi:10.7759/cureus.36970 · Cited by 2
Diabetes in Children and Adolescents
Lora, A. L. M., Espíndola, M. E., Paz, M. B., Díaz, J. M. M., & Klünder‐Klünder, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_64 · Cited by 1
Griggs, S. A., Huynh, J., Rieke, J. G., & Howard, Q. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231192352 · Cited by 2
Matulis, J. C., & McCoy, R. G. (2023) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2023.7884 · Cited by 1
Schroeder, A. E., Rosenkranz, R. R., Yarrow, L., Haub, M. D., & Rosenkranz, S. K. (2023) · Sports · doi:10.3390/sports11110214 · Cited by 3
“The athlete’s mean TIR during the current 8-day case study was 77%, which exceeds current ADA guidelines for TIR (i.e., > 70% TIR) [33].”
BackgroundInfluentialNasti, A., Okumura, M., Takeshita, Y., Ho, T. T. B., Sakai, Y., Sato, T., Nomura, C., Goto, H., Nakano, Y., Urabe, T., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111090 · Cited by 2
Lyons, R. E., Wahab, R. A., Goh, S. Y., Breen, C., Rhynehart, A., O'Scannail, M., Kelly, H. J., Neff, K., O'Shea, D. B., Canavan, R. J., et al. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.469 · Cited by 1
Insulin therapy: a century of continuing progress
Bolli, G. B., Fanelli, C. G., Lucidi, P., & Porcellati, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00006-1 · Cited by 1
Ali, A. M., Cobran, E. K., & Young, H. N. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01388-5 · Cited by 1
“Insufficient glycemic management has been associated with increased utilization of healthcare resources (e.g., emergency department (ED) visits, hospitalizations) [3, 4].”
Zuhair, V., Obaid, M. A., Mustafa, M. S., Shafique, M. A., Rangwala, B. S., Shakil, A., Babar, A., Rangwala, H. S., & Obaid, M. I. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01431-5 · Cited by 4
“…weekly insulin adjustment of 28 units and targeted a fasting glucose range of 80–130 mg/dL before breakfast under the guidelines set by the American Diabetes Association [28]. were doubled and tripled, which preceded the induction of hypoglycemia in order to analyze the Hypoglycemic symptoms score.”
Nath, A., Mathew, S., Pant, A., & Thadi, Y. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01471-x · Cited by 2
“Consistent monitoring and personalised reminders play a Further, the effect of treatment for type 2 diabetes takes time to reflect on the change of HbA1c, which indicates the glucose level over an average duration of three months [21].”
Viktorínová, A., Brnka, R., Pirošová, M., Pontuch, P., & Kiňová, S. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2024-0069 · Cited by 1
“%) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)-recommended SI units (in mmol/mol) (23).”
BackgroundBiological variation of capillary blood glucose: A systematic review
Zanette, K. D., & Martinello, F. (2024) · Biomedical Reports · doi:10.3892/br.2024.1885 · Cited by 4
Bunnel, K. T., Carvalho, S. J. E., Pereira, M. L., do Couto, R. O., & Baldoni, A. O. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100537 · Cited by 1
OS CUIDADOS ÀS PESSOAS COM DIABETES MELLITUS NA ATENÇÃO PRIMÁRIA À SAÚDE
Feitosa, A. D. N. A., Alexandre, B. D. S., Seabra, C. A. M., & Falcão, D. C. (2024) · Revista interdisciplinar em saúde · doi:10.35621/23587490.v11.n1.p1186-1199 · Cited by 1
Frequency of undiagnosed hypertension among diabetic patients with micro vascular complications
Qureshi, S. S., Amer, W., Mueez, M., Farok, M., & Shehzad, S. K. (2024) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.41.1.9715 · Cited by 2
Medina, L. A. C., Brandão, M. G. S. A., Lima, G. A., Zanetti, M. L., Pace, A. E., Serrano‐Gallardo, P., Gutiérrez-Valverde, J. M., de Oliveira, B. S. B., Lima, F. E. T., & Teixeira, C. R. D. S. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998344984241203070203 · Cited by 3
Hussien, A., Alkharasani, A. M., Alaboudi, Z. A., Alkhathran, S., Suliman, T. A., Alanazi, A. F., Ezzi, M. I., Almajid, G., Almutleeg, Z. H., & Msawa, M. A. (2025) · Cureus · doi:10.7759/cureus.85017
Relationship between type 2 diabetes and oral health status
Erdem, R. Z., Karaçam, K., & Apaydın, M. (2025) · Anatolian Current Medical Journal · doi:10.38053/acmj.1691889 · Cited by 1
How to reach optimal cardiovascular risk profile in carotid artery stenosis
Pitha, J. V. (2025) · International Angiology · doi:10.23736/s0392-9590.25.05442-2 · Cited by 1
Alphabet strategy for diabetes care: A checklist approach in the time of COVID-19 and beyond
Upreti, R., Lee, J. D., Kotecha, S., & Patel, V. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.407 · Cited by 2
Bailey, T. S., Evenou, P., Gill, J., Berhanu, P., Raymond, R., Strong, J. L., & Wright, E. E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0079 · Cited by 1
MERCADO-ASIS, L. B. (2021) · Series of Endocrinology Diabetes and Metabolism · doi:10.54178/jsedmv3i2004 · Cited by 1
Oli, J., Pant, V. P., Niraula, A., & Lamsal, M. (2022) · Journal of Nepal Medical Association · doi:10.31729/jnma.6998 · Cited by 2
Diabetes as a Metabolic Disease and Translational Exercise Medicine Informatics
Bao, T., & Shen, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-9162-1_10 · Cited by 1
Liu, N., Fujino, Y., Fujimoto, K., Ohtani, M., Imamura, H., & Matsuda, S. (2022) · Diabetology International · doi:10.1007/s13340-022-00584-z · Cited by 1
COMORBIDITY AND ITS IMPACT ON THE COURSE OF GOUT AND COVID-19
Smiyan, S., & Маховська, О. Ю. (2022) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2022.01.14 · Cited by 3
A judicious approach to ordering lab tests
Kaminski (2022) · The Journal of Family Practice · doi:10.12788/jfp.0444 · Cited by 1
Duman, T. T., Aktaş, G., Tel, B. M. A., Bilgin, S., Kahveci, G., & Kurtkulağı, Ö. (2022) · Journal of Public Health · doi:10.1007/s10389-022-01769-1 · Cited by 2
“The insulin treatment regimen to achieve the glycemic target may be different for each patient switched to insulin therapy (McMahon and Dluhy 2007; Working Group 2021a, b).”
Covid-19-associated mucormycosis in patients with renal failure
Patil, A., Rao, N., Kumar, K., Modi, T., Gandhi, C., Deb, S., Bose, S., Saxena, N., Katyal, A., Thakare, S. B., et al. (2022) · The National Medical Journal of India · doi:10.25259/nmji-35-3-187a · Cited by 1
Desigualdades sociales en la salud y el control de la diabetes mellitus tipo 2
Cuenca, A. M. C. (2022) · Diabetes práctica · doi:10.52102/diabet/pract/gestiondiabetes/art3 · Cited by 1
Kodama, S., Fujihara, K., Ishiguro, H., Matsubayashi, Y., Kitazawa, M., Iwanaga, M., Yamada, T., Kato, K., Nakagawa, Y., Tanaka, S., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221149188 · Cited by 1
Glycemic control metrics for in silico testing of artificial pancreas systems
Novák, K., Kovács, L., Drexler, D. A., & Eigner, G. (2022) · IEEE International Symposium on Computational Intelligence and Informatics (CINTI) · doi:10.1109/cinti-macro57952.2022.10029513 · Cited by 1
Chaithanya, R. (2023) · Journal of Internal Medicine and Emergency Research · doi:10.37191/mapsci-2582-7367-4(1)-056 · Cited by 2
Response to impaired awareness of hypoglycaemia in a study protocol
Almomani, H. Y., Pascual, C., Al-Azzam, S. I., & Ahmadi, K. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2021.03.001 · Cited by 1
Cardiovascular Autonomic Neuropathy
Ang, L. P., & Pop‐Busui, R. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_12 · Cited by 2
Systematic Review of Monogenic Diabetes PrognosticsPreprint
Naylor, R. N., Amouyal, C., Philipson, L. H., Vatier, C., Dickens, L. T., PMDI, A., & Greeley, S. A. W. (2023) · medRxiv · doi:10.1101/2023.05.19.23290220 · Cited by 1
Whole Pancreas and Islet Cell Transplantation
Marfil‐Garza, B. A., Senior, P. A., & Shapiro, A. M. J. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch34 · Cited by 1
Onyango, J. O., & Kiarie, R. (2024) · Research Square · doi:10.21203/rs.3.rs-4270600/v1 · Cited by 2
The Silver Linings of COVID-19
Gutierrez, L. (2021) · ADCES in Practice · doi:10.1177/2633559x211014602
Wangchuk, W., Chuki, P., Dorji, K. S., Dhendup, T., & Dorji, N. (2021) · Bhutan Health Journal · doi:10.47811/bhj.116
Williams, N. A., Brunton, S., & Scott, G. A. (2021) · Clinical Diabetes · doi:10.2337/cd21-0066 · Cited by 1
Bando, H. (2021) · Edelweiss Journal of Biomedical Research and Review · doi:10.33805/2690-2613.119 · Cited by 1
Les nouvelles thérapeutiques du diabète
Larger, É., Paul, M., & Alexandre‐Heymann, L. (2021) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2021.09.018
Himeno, N., Matsuda, T., & Yoneda, M. (2021) · Diabetology International · doi:10.1007/s13340-021-00527-0
Unusual association of cirrhosis and sickle cell anemia revealed by hemolytic anemia: A case report
Jallouli, A., Michouar, M., Laghfiri, N., Ait, E. A., Oubaha, S., Samlani, Z., & Krati, K. (2021) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000103
Evolution of Glycemic Targets in Management of Diabetes
Masood, M. Q. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115018
Li, Q., Zhang, Q., Wang, R., & Hong, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01182-z
Chiang, Y., Chang, C., Yu, H., Tsay, P., Lo, F., Chen, C., Lin, W., Hsu, C.-L., & Moons, P. (2021) · doi:10.2196/preprints.34921
La variación de la glucemia (GV), una experiencia personal
Montoreano, R. (2021) · Salus · doi:10.54139/salus.v25i1.52
Diabetes and Kidney Disease: A Review of the Clinical Practice Guidelines
Aggarwal, N., Ali, S., & Navaneethan, S. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_2
Pérez-Ortiz, J., González, A., Galarza-Bernita, D., & Cuenca, J. A. (2022) · Revista Ecuatoriana de Neurologia · doi:10.46997/revecuatneurol30300031
Kardiovaskuläre Risiken in der 4.–6. Lebensdekade mit Diabetes mellitus Typ 1
Lee-Barkey, Y. H., Stratmann, B., & Tschöpe, D. (2022) · Der Diabetologe · doi:10.1007/s11428-021-00854-5
Dib, A., Chartier, F., Ihle, K., Jamonneau, I., Ludwig, L., & Darmon, P. (2022) · Diabetes Therapy · doi:10.1007/s13300-021-01200-0
Metabolic and cardiovascular risk factors associated with type 1 Diabetes Mellitus in pediatric age
Araújo, M., & Correia, C. C. (2022) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar210013
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S73-S84
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4236126199
- Cited by
- 847
- References
- 118
- Citations by year
- 2026: 43 · 2025: 80 · 2024: 115 · 2023: 156 · 2022: 265 · 2021: 187 · 2020: 1
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, diabetes management, clinical guidelines, quality of care, level of evidence, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Endocrinology, Humans, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.